Application 078021
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
| 002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 10MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078021-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2007-07-17 | |
| A078021-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2007-07-17 | |
| A078021-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2007-07-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078021-001 | AB |
| A078021-002 | AB |
| A078021-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078021-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2007-07-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078021-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2007-07-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078021-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2007-07-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078021-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078021-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078021-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aurobindo Pharma Limited | b6f298ba-2d7e-4a3c-9edb-8b60aba716d6 | 2026-03-03 | Warnings, Adverse reactions | 078021 ANDA078021 65862-102 65862-101 65862-103 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64980-390 | Amlodipine Besylate | Amlodipine Besylate | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 64980-391 | Amlodipine Besylate | Amlodipine Besylate | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 64980-392 | Amlodipine Besylate | Amlodipine Besylate | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 65862-101 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-101 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-101 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-101 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-101 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-102 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-102 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-102 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-102 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-102 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-103 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-103 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-103 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-103 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-103 | Amlodipine Besylate | Amlodipine Besylate | Aurobindo Pharma Limited | ANDA | Current |